Baidu
map

Lancet:世卫组织称全球面临精神疾病危机:3亿抑郁症,5千万痴呆,6千万躁郁症

2018-10-21 佚名 中国循环杂志

近日,发表在Lancet上的一篇报告拉响了全球精神健康危机的警报。文章指出,全球日益严重的精神健康危机或会给公众、社区,以及全球经济带来持久的危害。

近日,发表在Lancet上的一篇报告拉响了全球精神健康危机的警报。文章指出,全球日益严重的精神健康危机或会给公众、社区,以及全球经济带来持久的危害。

据世界卫生组织估计,全球约有3亿人抑郁症患者,5000万痴呆症患者,2300万精神分裂症患者,6000万躁郁症患者。

报告称,全球精神健康问题凸显,如果不能妥善解决,那么从2010~2030年,精神健康问题会给全球经济造成高达16万亿美元的损失。

其中经济损失大部分是由于生产力下降,以及社会福利、教育和法治等方面开销加大。

虽然如此,但“没有一个国家投入了足够的力量”去解决本国人群精神健康问题。有学者表示,“没有任何其他的人类健康问题像精神健康问题一样被忽视。”

而且报告称,许多国家不幸罹患抑郁症、焦虑症和精神分裂症等的患者,经常遇到人权遭受严重侵犯的情况,包括被强制戴镣铐、虐待和监禁。

Lancet主编理查德·霍顿表示,报告凸显出“世界各地患有精神疾病的人所遭受令人不齿和震惊的灾难”。

该报告呼吁采取一种基于人权的方式,确保患有精神疾病的人不会被剥夺基本人权,包括就业、教育和其他核心生活经历。

该报告还建议大规模转向精神病患者的社区护理,采取心理社会疗法,比如不仅由专业医护人员而且由社区卫生工作者、同龄人、教师和牧师提供的谈话治疗。

原始出处:Helen Frankish, Niall Boyce, Richard Horton. Mental health for all: a global goal. Lancet. October 09, 2018.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1776843, encodeId=95a61e7684367, content=<a href='/topic/show?id=798f93186d3' target=_blank style='color:#2F92EE;'>#躁郁症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93186, encryptionId=798f93186d3, topicName=躁郁症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac0839038921, createdName=DEXTER3152, createdTime=Mon Apr 22 10:50:00 CST 2019, time=2019-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1829844, encodeId=98501829844ef, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Thu Feb 21 01:50:00 CST 2019, time=2019-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300845, encodeId=49ad13008457e, content=<a href='/topic/show?id=d6f720e61ab' target=_blank style='color:#2F92EE;'>#世卫组织#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20761, encryptionId=d6f720e61ab, topicName=世卫组织)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Mon Oct 22 17:50:00 CST 2018, time=2018-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=350018, encodeId=b4ec35001806, content=谢谢分享,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Sun Oct 21 07:08:48 CST 2018, time=2018-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1048505, encodeId=7e8a104850579, content=老年人痴呆何药可用??, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Sun Oct 21 05:50:00 CST 2018, time=2018-10-21, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1776843, encodeId=95a61e7684367, content=<a href='/topic/show?id=798f93186d3' target=_blank style='color:#2F92EE;'>#躁郁症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93186, encryptionId=798f93186d3, topicName=躁郁症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac0839038921, createdName=DEXTER3152, createdTime=Mon Apr 22 10:50:00 CST 2019, time=2019-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1829844, encodeId=98501829844ef, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Thu Feb 21 01:50:00 CST 2019, time=2019-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300845, encodeId=49ad13008457e, content=<a href='/topic/show?id=d6f720e61ab' target=_blank style='color:#2F92EE;'>#世卫组织#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20761, encryptionId=d6f720e61ab, topicName=世卫组织)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Mon Oct 22 17:50:00 CST 2018, time=2018-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=350018, encodeId=b4ec35001806, content=谢谢分享,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Sun Oct 21 07:08:48 CST 2018, time=2018-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1048505, encodeId=7e8a104850579, content=老年人痴呆何药可用??, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Sun Oct 21 05:50:00 CST 2018, time=2018-10-21, status=1, ipAttribution=)]
    2019-02-21 howi
  3. [GetPortalCommentsPageByObjectIdResponse(id=1776843, encodeId=95a61e7684367, content=<a href='/topic/show?id=798f93186d3' target=_blank style='color:#2F92EE;'>#躁郁症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93186, encryptionId=798f93186d3, topicName=躁郁症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac0839038921, createdName=DEXTER3152, createdTime=Mon Apr 22 10:50:00 CST 2019, time=2019-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1829844, encodeId=98501829844ef, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Thu Feb 21 01:50:00 CST 2019, time=2019-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300845, encodeId=49ad13008457e, content=<a href='/topic/show?id=d6f720e61ab' target=_blank style='color:#2F92EE;'>#世卫组织#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20761, encryptionId=d6f720e61ab, topicName=世卫组织)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Mon Oct 22 17:50:00 CST 2018, time=2018-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=350018, encodeId=b4ec35001806, content=谢谢分享,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Sun Oct 21 07:08:48 CST 2018, time=2018-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1048505, encodeId=7e8a104850579, content=老年人痴呆何药可用??, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Sun Oct 21 05:50:00 CST 2018, time=2018-10-21, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1776843, encodeId=95a61e7684367, content=<a href='/topic/show?id=798f93186d3' target=_blank style='color:#2F92EE;'>#躁郁症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93186, encryptionId=798f93186d3, topicName=躁郁症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac0839038921, createdName=DEXTER3152, createdTime=Mon Apr 22 10:50:00 CST 2019, time=2019-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1829844, encodeId=98501829844ef, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Thu Feb 21 01:50:00 CST 2019, time=2019-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300845, encodeId=49ad13008457e, content=<a href='/topic/show?id=d6f720e61ab' target=_blank style='color:#2F92EE;'>#世卫组织#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20761, encryptionId=d6f720e61ab, topicName=世卫组织)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Mon Oct 22 17:50:00 CST 2018, time=2018-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=350018, encodeId=b4ec35001806, content=谢谢分享,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Sun Oct 21 07:08:48 CST 2018, time=2018-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1048505, encodeId=7e8a104850579, content=老年人痴呆何药可用??, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Sun Oct 21 05:50:00 CST 2018, time=2018-10-21, status=1, ipAttribution=)]
    2018-10-21 明月清辉

    谢谢分享,学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1776843, encodeId=95a61e7684367, content=<a href='/topic/show?id=798f93186d3' target=_blank style='color:#2F92EE;'>#躁郁症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93186, encryptionId=798f93186d3, topicName=躁郁症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac0839038921, createdName=DEXTER3152, createdTime=Mon Apr 22 10:50:00 CST 2019, time=2019-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1829844, encodeId=98501829844ef, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Thu Feb 21 01:50:00 CST 2019, time=2019-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300845, encodeId=49ad13008457e, content=<a href='/topic/show?id=d6f720e61ab' target=_blank style='color:#2F92EE;'>#世卫组织#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20761, encryptionId=d6f720e61ab, topicName=世卫组织)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Mon Oct 22 17:50:00 CST 2018, time=2018-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=350018, encodeId=b4ec35001806, content=谢谢分享,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Sun Oct 21 07:08:48 CST 2018, time=2018-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1048505, encodeId=7e8a104850579, content=老年人痴呆何药可用??, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Sun Oct 21 05:50:00 CST 2018, time=2018-10-21, status=1, ipAttribution=)]
    2018-10-21 junJUN

    老年人痴呆何药可用??

    0

相关资讯

英国新研究探索:抑郁和焦虑会遗传吗?

英国研究人员正在募集40000名抑郁症或焦虑症患者加入一项在线调查,探索这些疾病之间的遗传关系。

J Neurosci:CRISPR介入抑郁症疗法,将开发副作用更小的药物

据估计,13 %的美国人服用抗抑郁药物对抗抑郁、焦虑、慢性疼痛或睡眠问题。然而对于1400万患有临床抑郁症的美国人来说,近三分之一得不到相关药物的缓解。近日,华盛顿大学医学院的研究人员正尝试一种基于CRISPR技术的新方法来缓解抑郁症。

Gut:抑郁症和抗抑郁治疗对炎症性肠病的影响

由此可见,抑郁症患者更容易被诊断为IBD。相比之下,抗抑郁治疗可选择性地预防克罗恩病和UC。这些结果可能会影响抑郁症与IBD的咨询和治疗。

Front Neurosci:抗抑郁药物为什么无效?揭开抑郁症真正病因及治疗手段

新研究表明线粒体可能是抑郁的根源,这将成为改善抑郁症治疗的一个新机遇。

Int J Cardiol:抑郁症、可治疗的心血管危险因素与心脏事件

由此可见,抑郁症与心脏事件之间的关联不太可能通过高血压、糖尿病或血脂异常的影响来解释。

西安杨森欧洲申请将依他胺鼻腔喷雾剂用于治疗抑郁症

西安杨森Janssen公司向欧洲药品管理局(EMA)提交了一份销售申请,要求批准其研究的依他胺鼻腔喷雾剂用于治疗重度抑郁症。

Baidu
map
Baidu
map
Baidu
map